BIOSCIENCE NEUTRACEUTICALS, INC. Debt Instrument, Convertible, Beneficial Conversion Feature
BIOSCIENCE NEUTRACEUTICALS, INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $137.31 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2019 was $137.31K.
- BIOSCIENCE NEUTRACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2017 was $22.88K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2019-12-31 | $137.31K 10-K · filed 2020-03-30 |
| 2017-12-31 | $22.88K 10-K · filed 2019-04-09 |